McAdam LLC’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
2,196
+2
| +0.1% | +$209 | 0.01% | 340 |
|
|
2025
Q1 | $256K | Buy |
+2,194
| New | +$256K | 0.02% | 283 |
|
|
2020
Q1 | – | Sell |
-2,114
| Closed | -$219K | – | 108 |
|
|
2019
Q4 | $219K | Buy |
+2,114
| New | +$219K | 0.05% | 81 |
|
|
2018
Q4 | – | Sell |
-2,000
| Closed | -$7K | – | 100 |
|
|
2018
Q3 | $7K | Hold |
2,000
| – | – | ﹤0.01% | 373 |
|
|
2018
Q2 | $6K | Buy |
+2,000
| New | +$6K | ﹤0.01% | 368 |
|